A systematic review of the use of economic evaluation in local decision-making.

OBJECTIVES In view of resource scarcity, decisions have to be made on the optimal allocation of resources and one possible option in health care is economic evaluation. Little is known, however, about the use of economic evaluation. The objectives of this review were to assimilate the empirical evidence on this topic, discuss the main findings, and explore the possible need for further work needed in this area. METHODS A total of 40 studies were included in the review from a range of countries. A systematic search strategy was used and data from papers were extracted in a systematic way. RESULTS Pharmacists and clinicians in the US are the most frequently sampled group and postal surveys was the most commonly used method. Despite some positive findings, in most cases there appear to be obstacles to the extensive use of economic evaluation in decision-making. Obstacles can be linked to three factors: (1) institutional and political; (2) cultural; (3) methodological factors associated with economic evaluation itself. CONCLUSION There has clearly been an increase in the use of economic evaluation over time, especially in the UK, whereas the US appears to have a deep rooted disfavour of the approach. However, there is still little known about the exact influence of economic evaluation at the local level. Whilst work conducted to date has been valuable in providing information about use and barriers to use, further qualitative work is needed to enrich and explain some of the findings from this review.

[1]  C. Ham,et al.  Health Policy in Britain , 1982 .

[2]  J. Schulenburg The Influence of Economic Evaluation Studies on Health Care Decision-Making: A European Survey , 2000 .

[3]  Economic evaluation in health care: the point of view of informed physicians. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  Douglas K. Martin,et al.  Priority setting for new technologies in medicine: qualitative case study , 2000, BMJ : British Medical Journal.

[5]  Maarten J. IJzerman,et al.  PRE-ASSESSMENT TO ASSESS THE MATCH BETWEEN COST-EFFECTIVENESS RESULTS AND DECISION MAKERS' INFORMATION NEEDS , 2003, International Journal of Technology Assessment in Health Care.

[6]  D. Hailey Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies. , 1997, Social science & medicine.

[7]  C. Mitton,et al.  Resource Allocation in Health Care: Health Economics and Beyond , 2003, Health Care Analysis.

[8]  N. Powe,et al.  The review process used by U.S. health care plans to evaluate new medical technology for coverage , 1996, Journal of General Internal Medicine.

[9]  D. McDaid,et al.  Evaluating health care interventions in the European Union. , 2003, Health policy.

[10]  C. Donaldson,et al.  Economics, Public Health and Health Care Purchasing: The Tayside Experience of Programme Budgeting and Marginal Analysis , 1996, Journal of health services research & policy.

[11]  J. Graf von der Schulenburg,et al.  The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. , 2000, Health policy.

[12]  P. Trueman,et al.  Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'? , 1999, Health policy.

[13]  Jeffrey K Aronson,et al.  The road to health care , 2004, BMJ : British Medical Journal.

[14]  J. Coast Is economic evaluation in touch with society's health values? , 2004, BMJ : British Medical Journal.

[15]  Sheila Leatherman,et al.  The business case for quality: case studies and an analysis. , 2003, Health affairs.

[16]  S. Sullivan,et al.  Economic evaluation in the US: what is the missing link? , 2006, PharmacoEconomics.

[17]  A. Ludbrook Economic appraisal in the National Health Service: a survey. , 1986, Health policy.

[18]  M. Drummond,et al.  Economic evaluation under managed competition: evidence from the U.K. , 1997, Social science & medicine.

[19]  J. Grand THE LABOUR GOVERNMENT AND THE NATIONAL HEALTH SERVICE , 2002 .

[20]  R. Rosen Applying Research to Health Care Policy and Practice: Medical and Managerial Views on Effectiveness and the Role of Research , 2000, Journal of health services research & policy.

[21]  M. Drummond,et al.  Economic evaluations of drug therapy: attitudes of primary care prescribing advisers in Great Britain. , 1997, Health policy.

[22]  S. Twaddle,et al.  Programme budgeting and marginal analysis: application within programmes to assist purchasing in Greater Glasgow Health Board. , 1995, Health policy.

[23]  Douglas K. Martin,et al.  Priority setting in a hospital drug formulary: a qualitative case study and evaluation. , 2003, Health policy.

[24]  K. Whetten-Goldstein,et al.  Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis. , 1997, Social science & medicine.

[25]  C. Mitton,et al.  Cost effectiveness analysis in health care: contraindications , 2002, BMJ : British Medical Journal.

[26]  Managed care pharmacy, socioeconomic assessments and drug adoption decisions. , 1997, Social science & medicine.

[27]  J. Eisenberg,et al.  Are we ready to use cost-effectiveness analysis in health care decision-making? A health services research challenge for clinicians, patients, health care systems, and public policy. , 1998, Medical care.

[28]  Rationality and reality: Attitudes of health economists working at local level in the UK National Health Service , 2001 .

[29]  M. Drummond,et al.  Using economic evidence to support decision making: a case study of assertive community treatment within the UK National Service Framework for Mental Health. , 2002, Applied health economics and health policy.

[30]  Economic evaluation of medical technologies in Sweden. , 1997, Social science & medicine.

[31]  J. Coast,et al.  Citizens, their agents and health care rationing: an exploratory study using qualitative methods. , 2001, Health economics.

[32]  J. Baron,et al.  The influence of cost-effectiveness information on physicians' cancer screening recommendations. , 2003, Social science & medicine.

[33]  Martina Garau,et al.  Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study , 2004, BMJ : British Medical Journal.

[34]  A. Anell,et al.  Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees. , 2000, PharmacoEconomics (Auckland).

[35]  Trevor A Sheldon,et al.  What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews , 2004, BMJ : British Medical Journal.

[36]  J. Ross,et al.  The use of economic evaluation in health care: Australian decision makers' perceptions. , 1995, Health policy.

[37]  M. Drummond,et al.  Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[38]  S. Duckett Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme , 2004, Health care financing review.

[39]  Douglas K. Martin,et al.  Priority-setting decisions for new cancer drugs: a qualitative case study , 2001, The Lancet.

[40]  P. Neumann Why don't Americans use cost-effectiveness analysis? , 2004, The American journal of managed care.

[41]  S. Peacock An evaluation of program budgeting and marginal analysis applied in South Australian hospitals , 1998 .

[42]  S. Bryan,et al.  Cost-effectiveness analysis and formulary decision making in England: findings from research. , 2007, Social science & medicine.

[43]  E. Adang,et al.  Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. , 2005, Health policy.

[44]  M. Drummond,et al.  Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[45]  Criteria to Request Pharmacoeconomic Data and Data Sources for Hospital Formulary Decisions , 2001 .

[46]  Ruth E. Brown,et al.  The Use of Technology Assessment by Hospitals, Health Maintenance Organizations, and Third-Party Payers in the United States , 1995, International Journal of Technology Assessment in Health Care.

[47]  S. Wilson Methods for the economic evaluation of health care programmes , 1987 .

[48]  N. Barber,et al.  What constitutes evidence in hospital new drug decision making? , 2004, Social science & medicine.

[49]  J. Collet,et al.  “Cost-effectiveness” Estimates Result in Flawed Decisionmaking in Listing Drugs for Reimbursement , 2002, Canadian journal of public health = Revue canadienne de sante publique.

[50]  Stirling Bryan,et al.  Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. , 2007, Health economics.

[51]  R. Kravitz,et al.  A survey of physician attitudes and practices concerning cost-effectiveness in patient care. , 2000, The Western journal of medicine.

[52]  F. Odedina,et al.  Use of pharmacoeconomic data in making hospital formulary decisions. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[53]  P. Marquis,et al.  Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey. , 2005, Health policy.

[54]  P. Johnstone,et al.  Are decisions by purchasers in an English health district evidence-based? , 2002, Journal of health services research & policy.

[55]  M. Drummond,et al.  Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology. , 1994, Social science & medicine.

[56]  N. Powe,et al.  Coverage Decisions for Medical Technology by Managed Care: Relationship to Organizational and Physician Payment Characteristics , 1996 .